🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Catheter directed retrograde venous infusion of gemcitabine/lipiodol into p...
Status
Withdrawn
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2019-07
Trial ID
NCT03865563
Treatments Being Tested
Primary: To compare the efficacy of TACE and TAIE. Secondary: To compare t...
Status
Unknown
Location
Queen Mary Hospital
Start Date
2004-03
Trial ID
NCT00563095
The aim of this study is to assess efficacy of the different adjuvant chemo...
Status
Unknown
Location
Liver Cancer Insitute, Zhongshan Hospital
Start Date
1999-10
Trial ID
NCT01033578
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of hepatic...
Status
Completed
Location
Dongguan People's Hospital
Start Date
2016-08
Trial ID
NCT02856126
To compare the prognosis and adverse reactions of unresectable hepatocellul...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-10
Trial ID
NCT05057104
This phase III, randomized, prospective clinical study, aiming to compare t...
Status
Completed
Location
Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center,
Start Date
2016-09
Trial ID
NCT03059238
Treatments Being Tested
The study will be a single-center, randomized Phase II study of conventiona...
Status
Withdrawn
Location
Smilow Cancer Center
Start Date
2016-06
Trial ID
NCT02908165
Primary Objective: To compare the efficacy of TACE vs. CyberKnife SBRT in ...
Status
Withdrawn
Location
Stanford University School of Medicine
Start Date
2011-02
Trial ID
NCT01327521
An open label randomized study to compare TATE versus TACE in patients with...
Status
Terminated
Location
University of California, Irvine
Start Date
2017-12-05
Trial ID
NCT03145558
Treatments Being Tested
We plan to conduct a prospective, two-arm, open-label phase Ⅱ study to eval...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07209384
Treatments Being Tested